• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct29
TUS-PHARMA released FY2025 9 Months Earnings on October 29 After-Market (BJT), actual revenue CNY 224.82 M, actual EPS CNY -0.0618
01:00
TUS-PHARMA released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 82.38 M, actual EPS CNY 0.0098
01:00
Oct22
TUS-PHARMA to Release FY2025 Q3 Earnings Report on October 30 After-Market BJT
02:10
Aug26
TUS-PHARMA released FY2025 Semi-Annual Earnings on August 26 Pre-Market (BJT), actual revenue CNY 142.44 M, actual EPS CNY -0.0717
01:00
TUS-PHARMA released FY2025 Q2 earnings on August 26 Pre-Market (BJT), actual revenue CNY 77.22 M, actual EPS CNY -0.0038
01:00
Aug19
TUS-PHARMA to Release FY2025 Semi-Annual Earnings on August 27, 2025 (BJT)
01:01

Schedules & Filings

Schedules
Filings
Oct29
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 82.38 M, Net Income 2.349 M, EPS 0.0098

Aug27
Earning Release(CST)

FY2025 Semi-Annual Earning Release

Aug26
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 77.22 M, Net Income -913.89 K, EPS -0.0038

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More